SCHEDULE: Context Capital Management Discloses 9.9% Stake in Gossamer Bio

Context Capital Management, LLC and its affiliates have reported beneficial ownership of 48,835,788 shares, representing 9.9% of the outstanding common stock of Gossamer Bio, Inc.

Summary

• Context Capital Management, LLC, along with individuals Michael S. Rosen, William D. Fertig, Charles E. Carnegie, and the fund Context Partners Master Fund, L.P., have filed a Schedule 13G.
• This filing indicates beneficial ownership of 48,835,788 shares of Gossamer Bio, Inc. common stock.
• This holding represents 9.9% of the company's outstanding common stock.
• The reporting persons state they are not filing as members of a group and each disclaims beneficial ownership except to the extent of their pecuniary interest.
• The percentage is based on 488,846,722 shares outstanding as of June 5, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports an existing ownership stake without providing new operational or financial information about the company itself.

Positives

• Context Capital Management has taken a significant stake, signaling confidence in Gossamer Bio's potential.
• The disclosure is clear and adheres to regulatory requirements, providing transparency to the market.

Negatives

• The filing explicitly states that each reporting person disclaims beneficial ownership beyond their pecuniary interest, which could imply a passive investment stance rather than an intent to control or influence.
• The filing does not provide specific reasons for the investment or future intentions, leaving room for speculation.

Risks

• The filing does not explicitly mention any risks associated with the investment or the company's operations.
• Potential future actions by Context Capital Management, such as increasing or decreasing their stake, could impact Gossamer Bio's stock price.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Gossamer Bio, Inc. It solely reports the ownership stake of Context Capital Management.

Management Comments

• "Each reporting person also disclaims beneficial ownership of the securities reported in this Schedule 13G, except to the extent of that person?s pecuniary interest therein."
• "In addition, the filing of this Schedule 13G on behalf of LP should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any of the securities covered by this Schedule 13G."

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate a passive investment approach by institutional investors. The 9.9% stake by Context Capital Management suggests a significant but non-controlling interest in Gossamer Bio, a biotechnology company.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant institutional investor's stake, which may influence market perception.
• Management: The company's management is aware of Context Capital Management's ownership level.
• Regulators: The filing ensures compliance with SEC reporting requirements.

Next Steps

• Context Capital Management may continue to hold or adjust its stake in Gossamer Bio.
• Gossamer Bio, Inc. will continue its operations and report future financial and operational updates as required.

Key Dates

Keywords

Gossamer Bio, Schedule 13G, Context Capital Management, Beneficial Ownership, SEC Filing, Investment, Stock, Common Stock, Delaware, Cayman Islands